Stage IVB Colorectal Cancer Recruiting Phase 1 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0068497 (Stage IVB Colorectal Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03373188VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal CancerTreatment